Skip to content

Sugammadex Impurity 20

Sugammadex Impurity 20

Product Description
CAT No.
ALN-S029066
CAS No.
NA
Mol. F.
C69H106O46S7
Mol. Wt.
1896
Stock
Please Inquire
RFQ
Smiles : OC([C@H]1O)[C@H](OC2O[C@H](CSCCC(O)=O)[C@@H](O3)[C@@H](O)[C@H]2O)[C@@H](CSCCC(O)=O)O[C@@H]1O[C@@H]([C@@H](O)[C@H]4O)[C@@H](CSCCC(O)=O)OC4O[C@H]([C@H](O)[C@@H]5OC6)[C@H]6OC5O[C@H](C(O)[C@@H]7O)[C@H](CSCCC(O)=O)O[C@H]7O[C@H](C(O)[C@@H]8O)[C@H](CSCCC(O)=O)O[C@H]8O[C@H](C(O)[C@@H]9O)[C@H](CSCCC(O)=O)O[C@H]9O[C@@H]%10[C@@H](CSCCC(O)=O)O[C@@H]3[C@H](O)C%10O

Analytical method development and validation for the estimation of sugammadex

By Parekh, Hemangi; Chokshi, Parin; Mashru, RajashreenFrom Journal of Drug Delivery and Therapeutics (2020), 10(1), 52-59.

Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay

By de Zwart Marcel A H; ten Bruggencate-Broeders Jolanda; van Hal Henk J M; Megens Rene H J J J; Frasa Helma W L H – From Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2011), 879(19), 1573-86.

Request For Quotation

Related Products